Abstract | BACKGROUND: METHODS AND RESULTS: Outcomes of 669 STEMI patients (<12 h chest pain, non shock, fibrinolysis eligible, <75 years) with transfer delay to PCI>90 min who received half-dose alteplase and full-dose abciximab and were immediately transferred for PCI were compared with primary PCI effects in 1311 patients with transfer delay <90 min. Mean time from symptom-onset to PCI was longer (357 ± 145 min vs. 201 ± 177; P<0.001) in facilitated PCI with reduced-dose fibrinolysis group. In-hospital and 12-month outcomes were similar in both groups, however bleeding events were more frequent in facilitated PCI group ( hemorrhagic stroke 0.9% vs. 0%; P<0.001; severe+moderate 5.5% vs. 2.3%; P<0.001). CONCLUSIONS: This is the first large report showing the safety and benefits of transportation with very long transfer delay (>90 min) for facilitated PCI with reduced-dose fibrinolysis in STEMI patients. In fact, pharmacological treatment (combotherapy) was effective in overcoming the deleterious effects of long time-delay on outcome, with similar survival as compared to short-time transportation, despite higher risk of major bleeding complication.
|
Authors | Dariusz Dudek, Artur Dziewierz, Zbigniew Siudak, Tomasz Rakowski, Jaroslaw Zalewski, Jacek Legutko, Waldemar Mielecki, Marianna Janion, Stanislaw Bartus, Marcin Kuta, Lukasz Rzeszutko, Giuseppe De Luca, Krzysztof Zmudka, Jacek S Dubiel |
Journal | International journal of cardiology
(Int J Cardiol)
Vol. 139
Issue 3
Pg. 218-27
(Mar 18 2010)
ISSN: 1874-1754 [Electronic] Netherlands |
PMID | 19036463
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2008. Published by Elsevier Ireland Ltd. |
Chemical References |
|
Topics |
- Aged
- Angioplasty, Balloon, Coronary
(methods)
- Female
- Fibrinolysis
(drug effects, physiology)
- Fibrinolytic Agents
(administration & dosage)
- Follow-Up Studies
- Hospitals, Community
(methods)
- Humans
- Male
- Middle Aged
- Myocardial Infarction
(epidemiology, therapy)
- Patient Transfer
(methods)
- Poland
(epidemiology)
- Registries
- Time Factors
- Treatment Outcome
|